Lessons learned from lung and liver in-vivo gene therapy: implications for the future. (2018)
Attributed to:
Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/14712598.2018.1506761
PubMed Identifier: 30067117
Publication URI: http://europepmc.org/abstract/MED/30067117
Type: Journal Article/Review
Volume: 18
Parent Publication: Expert opinion on biological therapy
Issue: 9
ISSN: 1471-2598